Human medicines European public assessment report (EPAR): Rekambys, rilpivirine, Date of authorisation: 17/12/2020, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 4 November 2025 - 16:15

Human medicines European public assessment report (EPAR): Rekambys, rilpivirine, Date of authorisation: 17/12/2020, Revision: 13, Status: Authorised

Committee for Advanced Therapies (CAT): 5-7 November 2025, European Medicines Agency, Amsterdam, the Netherlands, from 5 November 2025 to 7 November 2025

Submitted by Anonymous (not verified) on 4 November 2025 - 15:15

Committee for Advanced Therapies (CAT): 5-7 November 2025, European Medicines Agency, Amsterdam, the Netherlands, from 5 November 2025 to 7 November 2025

Standard operating procedure for processing of requests for fee reduction falling under paragraph 5 of Article 6 of Regulation (EU) 2024/568

Submitted by Anonymous (not verified) on 4 November 2025 - 14:23

Standard operating procedure for processing of requests for fee reduction falling under paragraph 5 of Article 6 of Regulation (EU) 2024/568

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More